|
| Press Releases |
|
 |
|
| Tuesday, May 28, 2024 |
|
|
CR Pharmaceutical Armed with Leading Advantages Releases Growth Potential and Achieves High-quality Sustainable Development |
| China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320.HK), recorded total revenue of RMB244,703.9 million last year, a 12.2% climb year-on-year, and net profit of RMB 7,775.0 million, a 16.8% increase year-on-year. more info >> |
|
| Monday, November 14, 2022 |
|
|
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again |
| China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022. more info >> |
|
| Monday, January 20, 2020 |
|
|
安捷證券第二輪藥品集採結果：降價主旋律不變，首推創新型龍頭 |
| 2020年01月17日，第二輪國家集採正式開標，結果如下：122家企業參與採購，33個(按通用名計)藥品的194個品規激烈厮殺，價格降幅超出市場預期。 more info >> |
|
| Tuesday, July 2, 2019 |
|
|
华润医药再度蝉联资本杰出中国企业成就奖 |
华润医药集团有限公司（「华润医药」或「集团」；股份编号：3320）欣然宣布，集团于《资本杂志》主办的第十四届「资本杰出中国企业成就奖」中再度获选为「资本杰出中国医药集团」，彰显集团在过去一年于业务上的杰出表现及其稳固的发展潜力。
more info >> |
|
|
華潤醫藥再度蟬聯資本傑出中國企業成就獎 |
華潤醫藥集團有限公司（「華潤醫藥」或「集團」；股份編號：3320）欣然宣佈，集團於《資本雜誌》主辦的第十四屆「資本傑出中國企業成就獎」中再度獲選為「資本傑出中國醫藥集團」，彰顯集團在過去一年於業務上的傑出表現及其穩固的發展潛力。
more info >> |
|
| Friday, August 25, 2017 |
|
|
华润医药中期业绩增长理想 实现收益约港币827亿元 |
| 华润医药集团有限公司（「华润医药」）或「集团」；股份编号：3320）公布截至2017年6月30日止年度（「期内」）的中期业绩。 more info >> |
|
|
華潤醫藥中期業績增長理想 實現收益約港幣827億元 |
| 華潤醫藥集團有限公司（「華潤醫藥」）或「集團」；股份編號：3320）公佈截至2017年6月30日止年度（「期內」）的中期業績。 more info >> |
|
|
China Resources Pharmaceutical Delivers Solid Interim Results; Half-year Revenue Reaches HK$82.7 Billion |
| China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320), announced its interim results for the six months ended 30 June 2017 ("Reporting Period"). more info >> |
|
| Monday, March 20, 2017 |
|
|
华润医药全年业绩稳健增长 实现收益约港币1,567亿元 |
华润医药集团有限公司（「华润医药」）或「集团」；股份编号：3320）公布截至2016年12月31日止年度（「年内」）的全年业绩。
more info >> |
|
|
華潤醫藥全年業績穩健增長 實現收益約港幣1,567億元 |
華潤醫藥集團有限公司（「華潤醫藥」）或「集團」；股份編號：3320）公佈截至2016年12月31日止年度（「年內」）的全年業績。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 13, 2025 21:34 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 13, 2025 21:32 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 21:30 HKT/SGT
|
|
|
NMPA已受理亿胜生物关于EB12-20145P（HLX04-O）用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Aug 13, 2025 21:25 HKT/SGT
|
|
|
潼關黃金獲納入MSCI全球小型股指數 資本市場影響力進一步提升
Aug 13, 2025 19:19 HKT/SGT
|
|
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 15:33 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 14:18 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 11:00 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 10:15 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸運觀眾現場觀賽 深度參與世界人形機器人運動會
Aug 13, 2025 09:58 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸运观众现场观赛 深度参与世界人形机器人运动会
Aug 13, 2025 09:43 HKT/SGT
|
|
|
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Aug 13, 2025 09:27 HKT/SGT
|
|
|
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Aug 13, 2025 09:27 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
